{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["El Ouaamari Y"],"funding":["Fondation Charcot","European Union's Horizon 2020 Research and Innovation Programme Marie Skłodowska-Curie grant","The Leverhulme Trust","Roche Belgium","Fritz-Thyssen Foundation","Universiteit Antwerpen","University of Antwerp BOF","Fonds Wetenschappelijk Onderzoek","FWO","Charcot Foundation"],"pagination":["2189-2205"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12436986"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["73(11)"],"pubmed_abstract":["Multiple sclerosis (MS) is a chronic neurological disorder involving immune-mediated demyelination and neurodegeneration in the central nervous system (CNS). Current therapies primarily target inflammation, with limited strategies to promote remyelination or neural repair. This study explores the therapeutic potential of Brain-Derived Neurotrophic Factor (BDNF) delivered via an adeno-associated virus (AAV) vector to enhance remyelination and improve cognitive function in a subchronic cuprizone (CPZ)-induced demyelination mouse model. Sixty female C57BL/6 mice were used, with half receiving a 7-week CPZ diet to induce oligodendrocyte loss. After demyelination, mice were treated with AAV-BDNF, AAV-eGFP, or saline injections into the corpus callosum (CC), followed by a 5-week recovery phase. "],"journal":["Glia"],"pubmed_title":["AAV-Based Intracerebral Administration of BDNF Promotes Myelin Repair and Cognitive Improvement After Cuprizone-Induced Demyelination."],"pmcid":["PMC12436986"],"funding_grant_id":["49061","I003420N","42551","I000123N","813263","Methusalem","860003"],"pubmed_authors":["Ricciardi L","Calus E","Marei W","Cools N","Verhoye M","Wens I","van der Heijden S","El Ouaamari Y","Ponsaerts P","De Waele J","Dombrowski Y","Peter A","Van Dam D","Van den Bos J","Kuhn S"],"additional_accession":[]},"is_claimable":false,"name":"AAV-Based Intracerebral Administration of BDNF Promotes Myelin Repair and Cognitive Improvement After Cuprizone-Induced Demyelination.","description":"Multiple sclerosis (MS) is a chronic neurological disorder involving immune-mediated demyelination and neurodegeneration in the central nervous system (CNS). Current therapies primarily target inflammation, with limited strategies to promote remyelination or neural repair. This study explores the therapeutic potential of Brain-Derived Neurotrophic Factor (BDNF) delivered via an adeno-associated virus (AAV) vector to enhance remyelination and improve cognitive function in a subchronic cuprizone (CPZ)-induced demyelination mouse model. Sixty female C57BL/6 mice were used, with half receiving a 7-week CPZ diet to induce oligodendrocyte loss. After demyelination, mice were treated with AAV-BDNF, AAV-eGFP, or saline injections into the corpus callosum (CC), followed by a 5-week recovery phase. ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Nov","modification":"2026-04-08T18:32:44.499Z","creation":"2026-04-08T09:46:24.097Z"},"accession":"S-EPMC12436986","cross_references":{"pubmed":["40765420"],"doi":["10.1002/glia.70058"]}}